共 50 条
- [24] Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease? BMC MEDICINE, 2012, 10
- [27] Reduced Content of α-Synuclein in Peripheral Blood Leukocytes of Patients with LRRK2-Associated Parkinson’s Disease Bulletin of Experimental Biology and Medicine, 2011, 150 : 679 - 681